Announcements Trials
Browse Landscape

Status

Completed 6

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 97Observational 6Expanded_access 1

Sponsor

Cancer Type

Plasma cell 4Lymphoid 3Other hematologic neoplasm 1

Conditions

Multiple Myeloma 3Lymphoma 2Neoplasms, Plasma Cell 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 446Surgical Procedures, Operative 164Observation 152Drug Therapy 142Radiotherapy 141Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 78Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 66Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 61Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Observational × plerixafor × Clear all
NCT03406091 2024-02-20

Detection of Poor Mobilizer (PM) in Multiple Myeloma (MM) Patients

Fondazione EMN Italy Onlus

Completed
300 enrolled
Plasma cell

Multiple Myeloma

NCT00741780 2015-03-24

Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662).

Sanofi

Completed
164 enrolled
Plasma cell

Multiple Myeloma

NCT01738373 2015-03-23

Registry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation

Sanofi

Completed
262 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT01141543 2014-07-18

Feasibility and Efficiency Study of Leukemic Cell Mobilization With Plerixafor Injection

University Health Network, Toronto

Completed
12 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00741325 2014-02-11

Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610).

Sanofi

Completed
178 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT01700608 2012-10-04

Prospective Observational Study on Plerixafor After Chemotherapy

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Completed
27 enrolled
LymphoidPlasma cell

Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡